Search
Recursion Pharmaceuticals Inc
RXRXAdd to Watchlist
3.000USD
+0.030+1.02%
Close 07-29 16:00（ET）Quotes delayed by 15 min
1.58BMarket Cap
LossP/E TTM
Recursion Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-29The current valuation score of Recursion Pharmaceuticals Inc is 6.47, ranking 323 out of 384 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.56, which is -27.49% below the recent high of -1.86 and -346.64% above the recent low of -11.43.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.